Add BrightSurf on Google Email

Science News for January 1, 2026


Researchers create cells that help the brain keep its cool

Scientists at Lund University have created a new method to directly reprogram glial cells into parvalbumin neurons, which can help regulate brain activity and potentially treat disorders such as schizophrenia and epilepsy. The breakthrough could lead to therapies that replace lost or damaged brain cells in the future.

SourceLund University·JournalScience Advances·TypeExperimental study·DateJan 1, 2026

ASTRO relaunches its foundation with a renewed focus and clearer identity to reflect accelerated progress in radiation oncology

The American Society for Radiation Oncology (ASTRO) has rebranded its research foundation as Speed of Light – The ASTRO Foundation, marking a renewed focus on advancing research and improving patient care. The new initiative aims to strengthen research collaborations and investments to drive progress in radiation oncology.

Dual-salt synergy in interface regulation: in situ atomic force microscopy reveals the stabilization mechanism for lithium metal batteries

Researchers found that combining LiDFOB and LiPF₆ in a dual-salt electrolyte regulates electrode interfaces, forming a double-layer cathode electrolyte interphase and a LiF-rich solid electrolyte interphase. This design lowers interfacial impedance, promotes uniform Li deposition, and enhances durability under cycling.

The global burden of leukemia, 1990–2021: a systematic analysis of prevalence, DALYs, and risk factors from the global burden of disease study

Leukemia prevalence increased by 28.0% globally from 1990 to 2021, alongside a 16.2% decline in disability-adjusted life years (DALYs). Chronic lymphocytic leukemia (CLL) is the most prevalent subtype, while acute myeloid leukemia (AML) contributes the largest proportion of DALYs.

SourceFAR Publishing Limited·JournalMed Research·TypeSystematic review·DateJan 1, 2026

AI-powered R&D acceleration: Insilico Medicine and Hisun Pharma nominate a preclinical candidate just 8 months after forming a strategic collaboration

Insilico Medicine and Hisun Pharma successfully nominated a preclinical candidate using AI-powered R&D in just 8 months after forming a strategic collaboration. The collaboration showcased the acceleration and efficiency gains that AI can bring to drug development, enabling the companies to enhance innovation in early-stage drug discov...

EAST Tokamak experiments exceed plasma density limit, offering new approach to fusion ignition

Researchers at EAST have successfully accessed a theorized 'density-free regime' for fusion plasmas, achieving stable operation at densities beyond conventional limits. This breakthrough provides new insights into overcoming one of the most persistent physical obstacles on the path toward nuclear fusion ignition.

SourceChinese Academy of Sciences Headquarters·JournalScience Advances·TypeExperimental study·DateJan 1, 2026